Hosted on MSN27d
BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thought
Of those tested for CHEK2 (122), for Lynch (69), or for RAD51C/D (15) genetic mutations, none were found. Somatic test results were available for 280 men whose cancer had spread elsewhere.
CURE6d
Understanding Genetic and Genomic Testing in Breast Cancer
Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami ...
The Scientist9mon
Keeping a CHEK on breast cancer
In 22 April Advanced Online Publication from Nature Genetics, Meijers-Heijboer and colleagues from the CHEK-Breast Cancer Consortium report the identification of a mutation in the CHEK2 gene that ...
News Medical29d
Study challenges role of BRCA1 mutation in prostate cancer initiation
Of those tested for CHEK2 (122), for Lynch (69), or for RAD51C/D (15) genetic mutations, none was found. Somatic test results were available for 280 men whose cancer had spread elsewhere.
UroToday10d
SES AUA 2025: Germline Testing for Renal Cancers – How Age and Tumor Characteristics Affect Pathogenic Variants
SESAUA annual meeting featured a kidney cancer session and a presentation by Dr. Robert Smith discussing how age and tumor ...
Fort Morgan Times24d
Am I at risk of breast cancer?
Mutations of CHEK2, a gene that suppresses tumors, and PTEN, a gene that controls how quickly cells multiply, can also increase your risk. • Dense breast tissue: Having dense breast tissue is a ...